Aratana Therapeutics, Inc. Net Profit Margin 2013-2019 | PETX
Aratana Therapeutics, Inc. net profit margin from 2013 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2019-03-31 | $0.04B | $-0.01B | -33.33% |
| 2018-12-31 | $0.04B | $-0.02B | -41.67% |
| 2018-09-30 | $0.04B | $-0.02B | -53.66% |
| 2018-06-30 | $0.03B | $-0.04B | -160.00% |
| 2018-03-31 | $0.03B | $-0.04B | -176.00% |
| 2017-12-31 | $0.03B | $-0.05B | -192.00% |
| 2017-09-30 | $0.02B | $-0.06B | -366.67% |
| 2017-06-30 | $0.01B | $-0.06B | -655.56% |
| 2017-03-31 | $0.04B | $-0.03B | -66.67% |
| 2016-12-31 | $0.04B | $-0.03B | -86.84% |
| 2016-09-30 | $0.04B | $-0.02B | -60.53% |
| 2016-06-30 | $0.04B | $-0.06B | -168.42% |
| 2016-03-31 | $0.00B | $-0.09B | inf% |
| 2015-12-31 | $0.00B | $-0.08B | inf% |
| 2015-09-30 | $0.00B | $-0.08B | inf% |
| 2015-06-30 | $0.00B | $-0.04B | inf% |
| 2015-03-31 | $0.00B | $-0.04B | inf% |
| 2014-12-31 | $0.00B | $-0.04B | inf% |
